Antiphospholipid antibody syndrome and reproduction

Current Opinion in Obstetrics and Gynecology

Volumn 26, Issue 4, 2014, Pages 260-265

  Kutteh, William H ^a,b  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b Fertility Associates of Memphis   (United States)

Author keywords

Antiphospholipid antibodies; Antiphospholipid antibody syndrome; Heparin; Recurrent pregnancy loss

Indexed keywords

ACETYLSALICYLIC ACID; CARDIOLIPIN ANTIBODY; HEPARIN; IMMUNOGLOBULIN; LOW MOLECULAR WEIGHT HEPARIN; LUPUS ANTICOAGULANT; ORAL CONTRACEPTIVE AGENT; PHOSPHOLIPID ANTIBODY; PREDNISONE; THYROTROPIN; FIBRINOLYTIC AGENT;

ABDOMINAL SURGERY; ANEMIA; ANTIPHOSPHOLIPID SYNDROME; BLEEDING; CLINICAL PROTOCOL; CONSENSUS; DIAGNOSTIC TEST; ECCHYMOSIS; EMBRYO DEVELOPMENT; EPIDURAL HEMATOMA; EVIDENCE BASED PRACTICE; FETUS HEART RATE; FIRST TRIMESTER PREGNANCY; HUMAN; IN VITRO STUDY; LABORATORY TEST; LIFESTYLE; MEDICAL SOCIETY; OPERATIVE BLOOD LOSS; OSTEOPOROSIS; PATHOPHYSIOLOGY; PLACENTA DEVELOPMENT; PRACTICE GUIDELINE; PREGNANCY TEST; PRIORITY JOURNAL; RECURRENT ABORTION; REPRODUCTION; REVIEW; THROMBOCYTOPENIA; UTERUS MALFORMATION; ABORTION, HABITUAL; DRUG EFFECTS; FEMALE; MATERNAL CARE; PREGNANCY; PROCEDURES; RISK REDUCTION;

ABORTION, HABITUAL; ANTIPHOSPHOLIPID SYNDROME; ASPIRIN; FEMALE; FIBRINOLYTIC AGENTS; HEPARIN; HUMANS; PRACTICE GUIDELINES AS TOPIC; PRECONCEPTION CARE; PREGNANCY; REPRODUCTION; RISK REDUCTION BEHAVIOR;

EID: 84904045304     PISSN: 1040872X     EISSN: 1473656X     Source Type: Journal    
DOI: 10.1097/GCO.0000000000000086     Document Type: Review

References (22)

1. Ernest JM, Marshburn PB, Kutteh WH. Obstetric antiphospholipid syndrome: an update on pathophysiology and management. Semin Reprod Med 2011; 29:522-539.
2. Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006; 4:295-306.
3. De Jesus GR, Agmon-Levin N, Andrade CA, et al. 14th International congress on Antiphospholipid Antibodies Task Force report on obstetric antiphospholipid syndrome. Autoimmun Rev 2014; 114:92?95.
4. Brezina PR, Kutteh WH. Classic and cutting-edge strategies for the management of early pregnancy loss. Obstet Gynecol Clin N Am 2014; 41:1-18.
5. Kutteh WH, Triplett DA. Thrombophilias and recurrent pregnancy loss. Semin Reprod Med 2006; 24:54-65.
6. Committee on Practice Bulletins-Obstetrics, American College Obstetricians and Gynecologists Practice Bulletin 132. Antiphospholipid syndrome. Obstet Gynecol 2012; 120:1514-1521.
7. Practice Committee of the American Society for Reproductive Medicine. Evaluation and treatment of recurrent pregnancy loss: a committee opinion. Fertil Steril 2012; 98:1102-1103.
8. Hill AB. The environment and disease: association or causation? Proc R Soc Med 1965; 58:295-300.
9. Kutteh WH, Odom LN. Evaluating recurrent pregnancy loss: the role of autoimmune testing. Soc Reprod Med 2012; 10:5-11.
10. Jaslow CR, Carney JL, Kutteh WH. Diagnostic factors identified in 1020 women with two verses three or more recurrent pregnancy losses. Fertil Steril 2010; 93:1234-1244.
11. Kutteh WH, Stovall DW, Schust DJ. Reproductive immunology. In: Strauss JF, Barbieri RL, editors. Yen and Jaffe's reproductive endocrinology, 7th ed. Philadelphia, PA: Elsevier Saunders; 2013. ; vol. 14. pp. 287-307.
12. Girardi G, Redecha P, Salmon JE. Heparin prevents antiphospholipid antibody- induced fetal loss by inhibiting complement activation. Nat Med 2004; 10:1222-1226.
13. Lim W. Complement and the antiphospholipid syndrome. Curr Opin Hematol 2011; 18:361-365.
14. Branch DW, Dudley DJ, Mitchell MD, et al. Immunoglobulin G fractions from patients with antiphospholipid antibodies cause fetal death in BALB/c mice: a model for autoimmune fetal loss. Am J Obstet Gynecol 1990; 163:210-216.
15. Stephenson M, Kutteh WH, Purkiss S, et al. Intravenous immunoglobulin and idiopathic secondary recurrent miscarriage: a randomized trial. Hum Reprod 2010; 25:2203-2209.
16. Lockshin MD, Druzin ML, Qamar T. Prednisone does not prevent recurrent fetal death in women with antiphospholipid antibody. Am J Obstet Gynecol 1989; 160:439-443.
17. Hauth JC, Goldenberg RL, Parker CR, et al. Low-dose aspirin: lack of association with an increase in abruption placentae or perinatal mortality. Obstet Gynecol 1995; 85:1055-1058.
18. Laskin CA, Bombardier C, Hannah ME, et al. Prednisone and aspirin in women with autoantibodies and unexplained recurrent fetal loss. N Engl J Med 1997; 337:148-153.
19. Kutteh WH. Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. Am J Obstet Gynecol 1996; 174:1584-1589.
20. Ziakas PD, Pavlou M, Voulgarelis M. Heparin treatment in antiphospholipid syndrome with recurrent pregnancy loss: a systematic review and metaanalysis. Obstet Gynecol 2010; 115:1256-1262.
21. Kutteh WH, Hinote CD. Antiphospholipid syndrome. Obstet Gynecol Clin N Am 2014; 41:113-132.
22. Arnaud L, Mathian A, Ruffatti A, et al. Efficacy of aspirin for the primary prevention of thrombosis in patients with antiphospholipid antibodies: an international and collaborative meta-analysis. Autoimmun Rev 2014; 13: 281-291.